Novartis announced that the World Health Organization (WHO) has granted prequalification for all three of its influenza A (H1N1) 2009 monovalent vaccines for supply to United Nations (UN) agencies: the cell culture-based and MF59 adjuvanted vaccine Celtura, the egg-based and MF59 adjuvanted vaccine Focetria as well as the egg-based A(H1N1) vaccine manufactured using the seasonal Fluvirin platform.
The details can be read here.
No comments:
Post a Comment